CircSEC31A Promotes the Malignant Progression of Non-Small Cell Lung Cancer Through Regulating SEC31A Expression via Sponging miR-376a

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.30207593
   PubMed Web of Science ®Google Scholar
• Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–454.29364287
   PubMed Web of Science ®Google Scholar
• Sekihara K, Hishida T, Yoshida J, et al. Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is ‘cured’ from postoperative recurrence? Eur J Cardiothorac Surg. 2017;52(3):522–528. doi:10.1093/ejcts/ezx12728482033
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Hansen TB, Venø MT, et al. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555–565. doi:10.1038/onc.2017.36128991235
   PubMed Web of Science ®Google Scholar
• Xu N, Chen S, Liu Y, et al. Profiles and bioinformatics analysis of differentially expressed circrnas in taxol-resistant non-small cell lung cancer cells. Cell Physiol Biochem. 2018;48(5):2046–2060. doi:10.1159/00049254330099455
   PubMedGoogle Scholar
• Van Der Steen N, Lyu Y, Hitzler AK, et al. The circular RNA landscape of non-small cell lung cancer cells. Cancers (Basel). 2020;12(5). doi:10.3390/cancers12051091.
   PubMed Web of Science ®Google Scholar
• Chen L, Nan A, Zhang N, et al. Circular RNA 100146 functions as an oncogene through direct binding to miR-361-3p and miR-615-5p in non-small cell lung cancer. Mol Cancer. 2019;18(1):13. doi:10.1186/s12943-019-0943-030665425
   PubMed Web of Science ®Google Scholar
• Wang L, Tong X, Zhou Z, et al. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer. Mol Cancer. 2018;17(1):140. doi:10.1186/s12943-018-0889-730261900
   PubMed Web of Science ®Google Scholar
• Cui J, Li W, Liu G, et al. A novel circular RNA, hsa_circ_0043278, acts as a potential biomarker and promotes non-small cell lung cancer cell proliferation and migration by regulating miR-520f. Artif Cells Nanomed Biotechnol. 2019;47(1):810–821. doi:10.1080/21691401.2019.157584730873868
   PubMed Web of Science ®Google Scholar
• Kim RN, Choi YL, Lee MS, et al. SEC31A-ALK fusion gene in lung adenocarcinoma. Cancer Res Treat. 2016;48(1):398–402. doi:10.4143/crt.2014.25425715771
   PubMed Web of Science ®Google Scholar
• Van Der Wekken AJ, Kuiper JL, Saber A, et al. Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression. PLoS One. 2017;12(8):e0182885. doi:10.1371/journal.pone.018288528854272
   PubMed Web of Science ®Google Scholar
• Jin M, Shi C, Hua Q, et al. High circ-SEC31A expression predicts unfavorable prognoses in non-small cell lung cancer by regulating the miR-520a-5p/GOT-2 axis. Aging. 2020;12(11):10381–10397. doi:10.18632/aging.10326432499446
   PubMedGoogle Scholar
• Wang Y, Cong W, Wu G, et al. MiR-376a suppresses the proliferation and invasion of non-small-cell lung cancer by targeting c-Myc. Cell Biol Int. 2018;42(1):25–33. doi:10.1002/cbin.1082828741879
   PubMed Web of Science ®Google Scholar
• Joerger M, Baty F, Früh M, et al. Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05). Lung Cancer. 2014;85(2):306–313. doi:10.1016/j.lungcan.2014.04.01424928469
   PubMed Web of Science ®Google Scholar
• Wang C, Tan S, Liu WR, et al. RNA-Seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma. Mol Cancer. 2019;18(1):134. doi:10.1186/s12943-019-1061-831484581
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng F, Xiao X, et al. CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells. EMBO Rep. 2017;18(9):1646–1659.28794202
   PubMed Web of Science ®Google Scholar
• Tang YY, Zhao P, Zou TN, et al. Circular RNA hsa_circ_0001982 promotes breast cancer cell carcinogenesis through decreasing miR-143. DNA Cell Biol. 2017;36(11):901–908. doi:10.1089/dna.2017.386228933584
   PubMed Web of Science ®Google Scholar
• Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12(4):381–388. doi:10.1080/15476286.2015.102027125746834
   PubMed Web of Science ®Google Scholar
• Koppenol WH, Bounds PL, Dang CV. Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11(5):325–337. doi:10.1038/nrc303821508971
   PubMed Web of Science ®Google Scholar
• Li J, Sun D, Pu W, et al. Circular RNAs in cancer: biogenesis, function, and clinical significance. Trends Cancer. 2020;6(4):319–336. doi:10.1016/j.trecan.2020.01.01232209446
   PubMed Web of Science ®Google Scholar
• Herr I, Sähr H, Zhao Z, et al. MiR-127 and miR-376a act as tumor suppressors by in vivo targeting of COA1 and PDIA6 in giant cell tumor of bone. Cancer Lett. 2017;409:49–55. doi:10.1016/j.canlet.2017.08.02928866093
   PubMed Web of Science ®Google Scholar
• Fellenberg J, Lehner B, Saehr H, et al. Tumor suppressor function of miR-127-3p and miR-376a-3p in osteosarcoma cells. Cancers (Basel). 2019;11(12). doi:10.3390/cancers11122019.
   PubMed Web of Science ®Google Scholar
• Zehavi L, Avraham R, Barzilai A, et al. Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor. Mol Cancer. 2012;11(44). doi:10.1186/1476-4598-11-44.
   PubMed Web of Science ®Google Scholar
• Yang L, Wei QM, Zhang XW, et al. MiR-376a promotion of proliferation and metastases in ovarian cancer: potential role as a biomarker. Life Sci. 2017;173:62–67. doi:10.1016/j.lfs.2016.12.00727979415
   PubMed Web of Science ®Google Scholar
• Meng X, Joosse SA, Müller V, et al. Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients. Br J Cancer. 2015;113(9):1358–1366. doi:10.1038/bjc.2015.34026393886
   PubMed Web of Science ®Google Scholar
• Dai D, Tan Y, Guo L, et al. Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing. Eur J Endocrinol. 2020;182(1):111–121. doi:10.1530/EJE-19-052431721725
   PubMed Web of Science ®Google Scholar
• Nadal E, Zhong J, Lin J, et al. A microRNA cluster at 14q32 drives aggressive lung adenocarcinoma. Clin Cancer Res. 2014;20(12):3107–3117. doi:10.1158/1078-0432.CCR-13-334824833665
   PubMed Web of Science ®Google Scholar
• Zhang PF, Pei X, Li KS, et al. Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells. Mol Cancer. 2019;18(1):179. doi:10.1186/s12943-019-1111-231815619
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang X, Hu B, et al. Circular RNA ZFR accelerates non-small cell lung cancer progression by acting as a miR-101-3p sponge to enhance CUL4B expression. Artif Cells Nanomed Biotechnol. 2019;47(1):3410–3416. doi:10.1080/21691401.2019.165262331407591
   PubMed Web of Science ®Google Scholar
• Li Y, Hu J, Li L, et al. Upregulated circular RNA circ_0016760 indicates unfavorable prognosis in NSCLC and promotes cell progression through miR-1287/GAGE1 axis. Biochem Biophys Res Commun. 2018;503(3):2089–2094. doi:10.1016/j.bbrc.2018.07.16430103946
   PubMed Web of Science ®Google Scholar